News &amp; Updates

Ambulatory serum levels of magnesium demonstrate an independent U-shaped association with mortality at 1 year among US veterans with heart failure (HF), reveals a study. The risk is lowest between 1.6 and 2.6 mg/dL and is increased at both lower higher and lower levels.

Serum magnesium levels predict mortality in veterans with HF

Sitting less, moving more reduce risk of adverse pregnancy outcomes

Pregnant women who minimize sedentary duration by engaging in light-intensity movement and increasing step count appear to have a reduced risk of adverse pregnancy outcomes, according to a study.

Sitting less, moving more reduce risk of adverse pregnancy outcomes

People with evidence of HBV at elevated risk of liver-related events

Hepatitis B virus (HBV) low-level viraemia (LLV) may increase the risk of liver-related events, as suggested in a study.

People with evidence of HBV at elevated risk of liver-related events

Ecopipam halves relapse risk in paediatric Tourette syndrome

06 Jun 2026 by

The phase 3 trial of the selective dopamine D1 receptor antagonist ecopipam has demonstrated maintenace of tic suppression for up to 24 weeks and reduction in the risk of relapse of 50 percent in children with Tourette syndrome.

Ecopipam halves relapse risk in paediatric Tourette syndrome

Dupilumab improves AD symptoms in adult Asians

06 Jun 2026 by

Treatment with dupilumab results in significant improvements in the signs and symptoms of moderate-to-severe atopic dermatitis (AD) in adult Asian patients without any serious adverse effects, a Singapore study has shown.

Dupilumab improves AD symptoms in adult Asians

06 Jun 2026

Low-insulinemic, planetary health diets good for weight management during menopause

For menopausal women, adopting low-insulinemic and planetary health diets—rich in nuts, legumes, fruits, vegetables, and whole grains and low in red or processed meats, sodium, and French fries—helps optimize weight and long-term cardiometabolic health, as shown in a study.

Low-insulinemic, planetary health diets good for weight management during menopause

Is EBRT after Y-90 safe for HCC patients?

External beam radiation therapy (EBRT) after Yttrium-90 radioembolization (Y-90) does not appear to worsen hepatoxicity or inferior oncologic outcomes in patients with hepatocellular carcinoma (HCC) when compared with EBRT alone, a study has shown.

Is EBRT after Y-90 safe for HCC patients?

Cabozantinib plus nivolumab, ipilimumab improves PFS in advanced renal cell carcinoma

05 Jun 2026 by

Adding cabozantinib to nivolumab and ipilimumab as first-line therapy, compared with placebo, results in prolonged progression-free survival (PFS) among untreated patients with advanced renal cell carcinoma (RCC), with no new safety signals seen, as shown by the results of the phase III COSMIC-313 study.

Cabozantinib plus nivolumab, ipilimumab improves PFS in advanced renal cell carcinoma

05 Jun 2026

FOLFIRI-ramucirumab shows promise as second-line therapy in advanced UGI cancers

Combination therapy with FOLFIRI-ramucirumab exhibits survival advantage similar to ramucirumab plus paclitaxel in patients with advanced upper gastrointestinal (UGI) cancers, reveals a study. However, FOLFIRI-ramucirumab is associated with a longer real-world time to treatment discontinuation (rwTTD).

FOLFIRI-ramucirumab shows promise as second-line therapy in advanced UGI cancers

Physical activity intensity matters more for chronic disease prevention

05 Jun 2026 by

Prioritizing physical activity (PA) intensity over volume may yield greater benefits for preventing most noncommunicable diseases (NCDs), a prospective study suggests.

Physical activity intensity matters more for chronic disease prevention